ÂÜÀòÂÒÂ×

Kim has deep global experience in the cell and gene therapy industry, biologics and medical device spaces, with a distinguished track record of innovation and implementation of Good Manufacturing Practices (GMP). Prior to joining Aspen Neuroscience, Kim served as Chief Manufacturing and Technology Officer and a member of the executive team at AVROBIO, a Boston-based leader in the gene therapy space. Before Avrobio, Kim was vice president of operations for Nikon CeLL innovation Co., Ltd, a Japanese contract development and manufacturing organization. During his tenure, he established the company as the preferred provider of custom process development and manufacturing services for cell and gene therapy products in the Japanese market. Previously, Kim held management positions at Lonza, serving as the business director for cell therapy contract manufacturing operations in Singapore for five years, and prior to that as director of operations at Lonza’s Maryland facilities. Kim was also previously the senior manager of the Tissue Processing Lab at CryoLife Inc. He holds a BS from the University of Miami and an MBA from Kennesaw State University.